Allspring Global Investments Holdings LLC bought a new position in shares of Ryan Specialty Holdings Inc. (NYSE:RYAN – Free Report) in the 2nd quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund bought 551,922 shares of the company’s stock, valued at approximately $37,321,000. Allspring Global Investments Holdings LLC owned approximately 0.21% of Ryan Specialty as of its most recent SEC filing.
Several other hedge funds and other institutional investors have also added to or reduced their stakes in the business. Principal Financial Group Inc. boosted its holdings in shares of Ryan Specialty by 66.4% in the 1st quarter. Principal Financial Group Inc. now owns 3,051,356 shares of the company’s stock worth $225,404,000 after purchasing an additional 1,218,147 shares in the last quarter. Invesco Ltd. boosted its holdings in shares of Ryan Specialty by 121.6% in the 1st quarter. Invesco Ltd. now owns 1,590,862 shares of the company’s stock worth $117,517,000 after purchasing an additional 872,846 shares in the last quarter. Artemis Investment Management LLP purchased a new position in shares of Ryan Specialty in the 1st quarter worth about $57,023,000. Woodline Partners LP purchased a new position in shares of Ryan Specialty in the 1st quarter worth about $40,278,000. Finally, Westfield Capital Management Co. LP boosted its holdings in shares of Ryan Specialty by 61.3% in the 1st quarter. Westfield Capital Management Co. LP now owns 1,078,233 shares of the company’s stock worth $79,649,000 after purchasing an additional 409,649 shares in the last quarter. 84.82% of the stock is currently owned by hedge funds and other institutional investors.
Insider Transactions at Ryan Specialty
In other Ryan Specialty news, Chairman Patrick G. Ryan purchased 276,634 shares of the firm’s stock in a transaction dated Friday, September 12th. The stock was purchased at an average price of $51.84 per share, for a total transaction of $14,340,706.56. Following the completion of the purchase, the chairman directly owned 13,699,959 shares of the company’s stock, valued at $710,205,874.56. This trade represents a 2.06% increase in their ownership of the stock. The acquisition was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. Insiders own 52.21% of the company’s stock.
Analysts Set New Price Targets
Get Our Latest Stock Report on RYAN
Ryan Specialty Stock Down 3.3%
Shares of NYSE:RYAN opened at $54.52 on Thursday. Ryan Specialty Holdings Inc. has a 52-week low of $50.08 and a 52-week high of $77.16. The firm has a market capitalization of $14.38 billion, a P/E ratio of 155.77, a P/E/G ratio of 1.55 and a beta of 0.63. The stock has a 50 day moving average price of $56.12 and a 200-day moving average price of $63.66. The company has a debt-to-equity ratio of 2.88, a quick ratio of 1.01 and a current ratio of 1.01.
Ryan Specialty (NYSE:RYAN – Get Free Report) last announced its earnings results on Thursday, July 31st. The company reported $0.66 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.66. Ryan Specialty had a return on equity of 48.70% and a net margin of 6.81%.The firm had revenue of $855.17 million during the quarter, compared to analyst estimates of $837.52 million. During the same quarter in the prior year, the company earned $0.58 EPS. The business’s revenue was up 23.0% compared to the same quarter last year. As a group, equities research analysts anticipate that Ryan Specialty Holdings Inc. will post 2.29 EPS for the current fiscal year.
Ryan Specialty Announces Dividend
The business also recently disclosed a quarterly dividend, which was paid on Tuesday, August 26th. Shareholders of record on Tuesday, August 12th were paid a dividend of $0.12 per share. The ex-dividend date was Tuesday, August 12th. This represents a $0.48 dividend on an annualized basis and a yield of 0.9%. Ryan Specialty’s payout ratio is presently 137.14%.
Ryan Specialty Profile
Ryan Specialty Holdings, Inc operates as a service provider of specialty products and solutions for insurance brokers, agents, and carriers in the United States, Canada, the United Kingdom, Europe, and Singapore. It offers distribution, underwriting, product development, administration, and risk management services by acting as a wholesale broker and a managing underwriter.
Featured Stories
- Five stocks we like better than Ryan Specialty
- Growth Stocks: What They Are, What They Are Not
- Palantir’s New Healthcare Deal Boosts AI and Data Reach
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- GM’s Billion-Dollar Bruise: GM’s Strategic Pivot Makes It a Buy
- The Significance of a Trillion-Dollar Market Cap Goes Beyond a Number
- Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead
Receive News & Ratings for Ryan Specialty Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ryan Specialty and related companies with MarketBeat.com's FREE daily email newsletter.